Pasithea Therapeutics, Corp. Disclosure
Pasithea Therapautic, Corp. is a client of TraDigital Marketing Group, Inc. Pasithea Therapautic, Corp. has a 3 month agreement in place, dated September 18, 2021 – December 17, 2021 to compensate TraDigital Marketing Group, Inc. a cash retainer of three hundred ninety-four thousand dollars ($394,000) paid as follows: a cash fee of three hundred ninety-four thousand USD($394,000) for investor relations services. Pasithea Therapautic, Corp. has paid TraDigital Marketing Group, LLC a one-time stock fee of 150,000 shares of common stock, restricted under Rule 144, for TraDigital Marketing Group, Inc., investor awareness and digital marketing services. The stock is eligible for sale on 03/17/2022. It is TraDigital’s intention to sell all of our shares once the restriction is lifted on 03/17/2022.
Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. TraDigital Marketing Group, Inc., investor awareness and advisory services include multimedia marketing and other awareness services.